Is Armis Centrix™ for VIPR Pro a good alternative to Claroty Exposure Management?

Armis Centrix™ for VIPR Pro and Claroty Exposure Management serve similar Exposure Management use cases: both are Exposure Management tools. Review the feature comparison above to determine which fits your requirements.

Armis Centrix™ for VIPR Pro vs Claroty Exposure Management (2026)

Q: What is the difference between Armis Centrix™ for VIPR Pro vs Claroty Exposure Management?

**Armis Centrix™ for VIPR Pro**: AI-powered vuln mgmt platform for prioritization & remediation workflows. built by Armis. headquartered in United States. Core capabilities include Consolidation of security findings from multiple detection tools, AI-powered risk prioritization and assessment, Grouping of alerts by common fix to reduce volume.. **Claroty Exposure Management**: Exposure management platform for cyber-physical systems (CPS) security. built by Claroty. headquartered in United States. Core capabilities include AI-driven CPS library for visibility and vulnerability attribution, Multiple asset discovery methods including passive monitoring and safe queries, Project file analysis for asset identification.. Both serve the Exposure Management market but differ in approach, feature depth, and target audience.

Q: What features do Armis Centrix™ for VIPR Pro vs Claroty Exposure Management offer?

**Armis Centrix™ for VIPR Pro** differentiates with Consolidation of security findings from multiple detection tools, AI-powered risk prioritization and assessment, Grouping of alerts by common fix to reduce volume. **Claroty Exposure Management** differentiates with AI-driven CPS library for visibility and vulnerability attribution, Multiple asset discovery methods including passive monitoring and safe queries, Project file analysis for asset identification.

Q: Who makes Armis Centrix™ for VIPR Pro vs Claroty Exposure Management?

**Armis Centrix™ for VIPR Pro** is developed by Armis. **Claroty Exposure Management** is developed by Claroty. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.